152 related articles for article (PubMed ID: 33107616)
1. Identification of miRNAs associated with dendritic cell dysfunction during acute and chronic hepatitis B virus infection.
Singh AK; Rooge SB; Varshney A; Vasudevan M; Kumar M; Geffers R; Kumar V; Sarin SK
J Med Virol; 2021 Jun; 93(6):3697-3706. PubMed ID: 33107616
[TBL] [Abstract][Full Text] [Related]
2. Global microRNA expression profiling in the liver biopsies of hepatitis B virus-infected patients suggests specific microRNA signatures for viral persistence and hepatocellular injury.
Singh AK; Rooge SB; Varshney A; Vasudevan M; Bhardwaj A; Venugopal SK; Trehanpati N; Kumar M; Geffers R; Kumar V; Sarin SK
Hepatology; 2018 May; 67(5):1695-1709. PubMed ID: 29194684
[TBL] [Abstract][Full Text] [Related]
3. Plasma MicroRNA Levels Are Associated With Hepatitis B e Antigen Status and Treatment Response in Chronic Hepatitis B Patients.
van der Ree MH; Jansen L; Kruize Z; van Nuenen AC; van Dort KA; Takkenberg RB; Reesink HW; Kootstra NA
J Infect Dis; 2017 May; 215(9):1421-1429. PubMed ID: 28368488
[TBL] [Abstract][Full Text] [Related]
4. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma.
Giray BG; Emekdas G; Tezcan S; Ulger M; Serin MS; Sezgin O; Altintas E; Tiftik EN
Mol Biol Rep; 2014 Jul; 41(7):4513-9. PubMed ID: 24595450
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA profile in HBV-induced infection and hepatocellular carcinoma.
Wang G; Dong F; Xu Z; Sharma S; Hu X; Chen D; Zhang L; Zhang J; Dong Q
BMC Cancer; 2017 Dec; 17(1):805. PubMed ID: 29191172
[TBL] [Abstract][Full Text] [Related]
6. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma.
Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P
PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus and hepatocellular carcinoma at the miRNA level.
Zhang ZZ; Liu X; Wang DQ; Teng MK; Niu LW; Huang AL; Liang Z
World J Gastroenterol; 2011 Jul; 17(28):3353-8. PubMed ID: 21876625
[TBL] [Abstract][Full Text] [Related]
9. The expression of miR-125b-5p is increased in the serum of patients with chronic hepatitis B infection and inhibits the detection of hepatitis B virus surface antigen.
Ninomiya M; Kondo Y; Kimura O; Funayama R; Nagashima T; Kogure T; Morosawa T; Tanaka Y; Nakayama K; Shimosegawa T
J Viral Hepat; 2016 May; 23(5):330-9. PubMed ID: 26924666
[TBL] [Abstract][Full Text] [Related]
10. A serum microRNA signature is associated with the immune control of chronic hepatitis B virus infection.
Brunetto MR; Cavallone D; Oliveri F; Moriconi F; Colombatto P; Coco B; Ciccorossi P; Rastelli C; Romagnoli V; Cherubini B; Teilum MW; Blondal T; Bonino F
PLoS One; 2014; 9(10):e110782. PubMed ID: 25350115
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma.
Huang DP; Zeng YH; Yuan WQ; Huang XF; Chen SQ; Wang MY; Qiu YJ; Tong GD
Int J Med Sci; 2021; 18(2):335-346. PubMed ID: 33390802
[No Abstract] [Full Text] [Related]
12. Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma.
Wang W; Zhao LJ; Tan YX; Ren H; Qi ZT
World J Gastroenterol; 2012 Oct; 18(38):5442-53. PubMed ID: 23082062
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.
Bandiera S; Pernot S; El Saghire H; Durand SC; Thumann C; Crouchet E; Ye T; Fofana I; Oudot MA; Barths J; Schuster C; Pessaux P; Heim MH; Baumert TF; Zeisel MB
J Virol; 2016 Jul; 90(14):6387-6400. PubMed ID: 27147737
[TBL] [Abstract][Full Text] [Related]
14. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
[TBL] [Abstract][Full Text] [Related]
15. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B Virus-Encoded MicroRNA (HBV-miR-3) Regulates Host Gene PPM1A Related to Hepatocellular Carcinoma.
Chavalit T; Nimsamer P; Sirivassanametha K; Anuntakarun S; Saengchoowong S; Tangkijvanich P; Payungporn S
Microrna; 2020; 9(3):232-239. PubMed ID: 31686644
[TBL] [Abstract][Full Text] [Related]
17. MiRNA/mRNA network topology in hepatitis virus B-related liver cirrhosis reveals miR-20a-5p/340-5p as hubs initiating fibrosis.
Yao H; Li P; Xin J; Liang X; Jiang J; Shi D; Li J; Hassan HM; Chen X; Li J
BMC Med Genomics; 2022 Nov; 15(1):240. PubMed ID: 36376845
[TBL] [Abstract][Full Text] [Related]
18. Differences in serum microRNA profiles in hepatitis B and C virus infection.
Akamatsu S; Hayes CN; Tsuge M; Miki D; Akiyama R; Abe H; Ochi H; Hiraga N; Imamura M; Takahashi S; Aikata H; Kawaoka T; Kawakami Y; Ohishi W; Chayama K
J Infect; 2015 Mar; 70(3):273-87. PubMed ID: 25452043
[TBL] [Abstract][Full Text] [Related]
19. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
Ghosh S; Bhowmik S; Majumdar S; Goswami A; Chakraborty J; Gupta S; Aggarwal S; Ray S; Chatterjee R; Bhattacharyya S; Dutta M; Datta S; Chowdhury A; Dhali GK; Banerjee S
Int J Cancer; 2020 Nov; 147(10):2934-2947. PubMed ID: 32441313
[TBL] [Abstract][Full Text] [Related]
20. MiR-185-5p suppresses HBV gene expression by targeting ELK1 in hepatoma carcinoma cells.
Fan HX; Feng YJ; Zhao XP; He YZ; Tang H
Life Sci; 2018 Nov; 213():9-17. PubMed ID: 30308183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
